Probability model of dibunol pharmakinetics.

Area of Science:

• Pharmacokinetics and Mathematical Modeling
• Drug Distribution and Metabolism
• Biomedical Engineering

Background:

• Understanding drug behavior within the body is crucial for effective therapeutic strategies.
• Dibunol's distribution and tissue accumulation dynamics require quantitative characterization.
• Optimizing drug delivery systems enhances therapeutic outcomes.

Purpose of the Study:

• To develop a mathematical model describing dibunol pharmacokinetics.
• To quantitatively characterize dibunol's inflow, distribution, and tissue accumulation.
• To evaluate different pharmaceutical formulations for optimal dibunol delivery.

Main Methods:

• Mathematical modeling of drug inflow and distribution.
• Quantitative analysis of dibunol behavior in experimental animals and humans.
• Comparative evaluation of various medicinal forms, including microencapsulation.

Main Results:

• A pharmacokinetic model for dibunol was established, detailing tissue accumulation and blood transfer mechanisms.
• Parameters quantifying dibunol's behavior in vivo were determined.
• Oral microencapsulated dibunol demonstrated superior absorbability, with theoretical concentrations matching observed human tumor levels.

Conclusions:

• The developed pharmacokinetic model accurately predicts dibunol tissue concentrations based on administration route and formulation.
• Microencapsulated dibunol is the optimal medicinal form for oral administration due to maximum absorbability.
• The model's validation in human tumor studies supports its clinical applicability.